Novartis signs one of the year's largest biobuck deals with Shanghai biotech Argo

For the second day in a row, Novartis is promising billions of dollars in biobucks to a company developing siRNA medicines. This time, Novartis is returning to a familiar face in Shanghai. The Swiss drugmaker ...